CHRNA7 has been implicated in the regulation of inflammation in non-alcoholic fatty liver disease [39], while CXCR5 is known to play a role in cancer-related inflammation and immune responses [40]. Here, CXCR5 is linked to metabolic dysfunction-associated steatotic liver disease.